CALL US: 206.533.3854
CALL US  206.533.3854

CALL US: 206.533.3854

SECTORS

HIGH
TECHNOLOGY

Artificial Intelligence

Blockchain & Cryptocurrency

Computer Technology & Software

Consumer Electronics

Electrical Devices

MECHANICAL
& PRODUCTS​

Cleantech

Mechanical Devices

Consumer & Retail Products

Hardware & Tools

Toys & Games

LIFE SCIENCES
& CHEMISTRY​

Biotechnology

Chemical Compounds

Digital Health

Healthcare Products

Pharmaceuticals

BRANDING
& CREATIVE​

Books & Publications

Brand Creation

Luxury Products

Photography & Video

Product Design

Public Domain, https://commons.wikimedia.org/w/index.php?curid=10532805

Congress to Expand Patent Eligibility for Computer-Implemented Inventions?

Bill would remove “new”
From patent act language;
Witnesses object

Earlier this year, Senators Thom Tillis (R-NC) and Chris Coons (D-DE) of the Senate Judiciary Committee, along with three members of the House of Representatives, released a draft patent reform bill focusing on 35 U.S.C. § 101.

This core section of the law defines what makes something patentable, and currently states:

Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.


(Emphasis added.)

The proposed new version of the law would remove the word “new.”


The word “new” relates to traditional patent requirements of novelty and non-obviousness, and shifts the patentability focus to the utility of the claimed invention.

Hearings on the proposed change were held in June.

Many witnesses spoke against loosening patent eligibility. For example, a witness from the Electronic Frontier Foundation testified:

Rewriting Section 101 to remove long-standing protections may benefit big businesses, patent trolls, and incumbents with massive patent portfolios, but it will disproportionately imperil startups, independent developers, customers, and end users.


The change in the law would reverse recent US Supreme Court precedents restricting subject matter eligibility.

In addition, the bill would direct the Patent Office to construe section 101 in favor of eligibility.

Also, judicial exceptions to subject-matter eligibility – such as “abstract ideas,” “laws of nature,” or “natural phenomena,” would not be recognized. Even more radically, cases that established or interpreted such exceptions would be abrogated by the statute.

After years in which the scope of patent protection narrowed – especially with respect to computer-aided inventions and business methods – it’s now widening again.

As we discussed earlier this year, the Patent Office updated its examination guidelines yet again in January in recognition that trying distinguish between “abstract ideas” (that aren’t patentable) and non-abstract inventions (that are patentable) has proved problematic.

Related Articles

Federal Circuit: IPR Estoppel Doesn’t Reach System Prior Art

The federal circuit has resolved a longstanding split among district courts by ruling that IPR estoppel does not reach system prior art even when evidenced ...
Read More

Photographer Awarded Almost $3000 in Copyright Small Claims Case

"Conor McGregor in 2015" by Andrius Petrucenia on Flickr (Original version) UCinternational (Crop) is licensed under CC BY-SA 2.0.
Read More

Federal Circuit Distinguishes between “Consist” and “Comprise”

Federal Circuit:
“Consist” does not mean “comprise”;
Other stuff disclaimed
Read More

Let's work together.

Contact us to set up a meeting with an attorney or team member.

Stay Informed

Sign up to receive Patent Poetry—a monthly roundup of key IP issues in our signature haiku format. Four articles (only 68 syllables); zero hassle.

SECTORS

HIGH
TECHNOLOGY

Artificial Intelligence

Blockchain & Cryptocurrency

Computer Technology & Software

Consumer Electronics

Electrical Devices

MECHANICAL
& PRODUCTS​

Cleantech

Mechanical Devices

Consumer & Retail Products

Hardware & Tools

Toys & Games

LIFE SCIENCES
& CHEMISTRY​

Biotechnology

Chemical Compounds

Digital Health

Healthcare Products

Pharmaceuticals

BRANDING
& CREATIVE​

Books & Publications

Brand Creation

Luxury Products

Photography & Video

Product Design

call us  206.533.3854